Loading…
Loading…
Toronto, Ontario--(Newsfile Corp. - June 8, 2026) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a provider of consumer heart monitoring, remote patient monitoring and medical electrocardiogram ("ECG") software solutions, is pleased to announce that it has entered into a strategic collaboration, joint development and intellectual property agreement with Predictiv AI Inc. ("Predictiv AI") of North York, Ontario. The agreement establishes a framework under which the companies may identify, assess and, where mutually approved, pursue specific projects involving healthcare software, medical software, artificial intelligence, automated analytics, remote patient monitoring, clinical decision support, biosignal interpretation, predictive analytics, workflow optimization and software as a medical device applications.
Toronto, Ontario--(Newsfile Corp. - May 8, 2026) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leader in consumer heart monitoring, remote patient monitoring, and medical electrocardiogram ("ECG") software solutions, announces that it has elected to rely on Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers and move to semi-annual financial reporting ("SAR"). Coordinated Blanket Order 51-933 allows eligible venture issuers listed on the TSX Venture Exchange (the "TSXV") to voluntarily move from a quarterly to a semi-annual financial reporting framework.
Funding will be used to a advance GEMS Flex And 14-Day Holter/LTCM ECG Platform Toronto, Ontario--(Newsfile Corp. - November 10, 2025) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, is pleased to announce that it has received approval from the TSX Venture Exchange for its November 3, 2025 announced loan agreement dated November 3, 2025 (the "Loan Agreement") representing aggregate funding of $512,000. The Loan Agreement provides new working capital to complete and commercialize the Company's GEMS FLEX and 14-day Holter and Event long term continuous monitoring ("LTCM") ECG software platform (the "Flagship Product").
Toronto, Ontario--(Newsfile Corp. - November 4, 2025) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it has terminated a royalty agreement announced October 1, 2025 (the "Royalty Agreement) and entered into a loan agreement dated November 3, 2025 (the "Loan Agreement") with current debt lenders to the Company (the "Lenders") for aggregate funding of $512,000. A copy of the Loan Agreement has been filed by the Company on SEDAR+.
Funding to Support Commercial Launch of Flagship 14 Day Holter-Event GEMS Software Platform Toronto, Ontario--(Newsfile Corp. - October 1, 2025) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it has entered into a royalty-based financing arrangement (the "Royalty Agreement") with current debt lenders to the Company (the "Lenders") in order secure new capital required to complete and commercialize the Company's new flagship GEMS FLEX and 14 day Holter and Event long term continuous monitoring ("LTCM") ECG software platform (the "Flagship Product"). The Royalty Agreement will also assist the Company in assuming all existing, interest-bearing loans.
Deal Consolidates All Debt Under Insider Control Toronto, Ontario--(Newsfile Corp. - September 26, 2025) - CardioComm Solutions Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced that its Chief Executive Officer, Mr. Etienne Grima, has purchased from one of the Company's lenders a loan with a principal value of $80,000 (the "Loan").
Toronto, Ontario--(Newsfile Corp. - August 1, 2025) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it has closed its previously announced shares for debt transactions with each of the four directors of the Company (see the Company's news release dated July 25, 2025). Pursuant to debt settlement agreements dated as of July 24, 2025 between the Company and each director, the Company has issued an aggregate of 4,162,500 common shares of the Company ("Shares") at a deemed price of $0.01 per Share to settle an aggregate of $41,625 in outstanding debt owed by the Company to the directors, as follows: Etienne Grima received 1,192,500 shares in settlement of $11,925 of debt; Robert Caines received 1,230,000 shares in settlement of $12,300 of debt; Daniel Grima received 1,080,000 shares in settlement of $10,800 of debt; and Robin Black received 660,000 shares in settlement of $6,600 of debt.
Toronto, Ontario--(Newsfile Corp. - July 25, 2025) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it has entered into debt settlement agreements with each of the directors of the Company, pursuant to which the Company will issue an aggregate of 4,162,500 common shares of the Company ("Shares") at a deemed price of $0.01 per Share to settle an aggregate of $41,625 in outstanding debt owed by the Company to the directors for services provided. When issued, the Shares will be subject to a four month hold period in accordance with applicable securities laws and the policies of the TSX Venture Exchange.
No recent filings indexed.